Trials / Completed
CompletedNCT03769493
Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)
Mobile After-Care Support Intervention for Patients With Schizophrenia Following Hospitalization (MACS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Butler Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.
Detailed description
In the open trial, all participants will receive a study-developed app to be used on a mobile phone. This app will support the use of healthy coping skills post-hospitalization, as well as help participants adhere to their discharge treatment plan. This phase is intended to inform the feasibility and acceptability of the app in preparation for a future randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mobile After-Care Support (MACS) app | The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning. Additionally, MACS encourages participants who are already reporting adherence and healthy coping by using positive reinforcement strategies to maintain efforts and promote additional goal setting. MACS app strategies are linked to participants' specific assessment responses, allowing for a highly personalized self-management intervention experience. The MACS app provides interactive exercises delivered by the device designed to teach patients coping skills that they can use now and in the future. |
Timeline
- Start date
- 2019-01-16
- Primary completion
- 2019-10-15
- Completion
- 2019-10-15
- First posted
- 2018-12-07
- Last updated
- 2023-01-19
- Results posted
- 2023-01-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03769493. Inclusion in this directory is not an endorsement.